South Africa withdraws TB drugs because of quality concerns

P. Sidley
DOI: https://doi.org/10.1136/bmj.a1385
2008-08-20
British Medical Journal
Abstract:South African health authorities have withdrawn two generic drugs widely used in the country to treat tuberculosis, amid concerns about their quality. When the health minister, Manto Tshabalala-Msimang, announced the withdrawal earlier this month she said that her department had received information suggesting that the ingredients in the two combination drugs, called Antib-4 and Ebsar, “were not at the level stated in the label after storage.” Antib-4 combines pyrazinamide, ethambutol, isoniazid, and rifampicin. Ebsar is a combination of isoniazid and rifampicin. Both drugs are manufactured in India by Rusan Pharma and imported into South Africa, where they are …
What problem does this paper attempt to address?